Literature DB >> 30902456

Surgical management of pediatric thyroid disease: Complication rates after thyroidectomy at the Children's Hospital of Philadelphia high-volume Pediatric Thyroid Center.

Heron D Baumgarten1, Andrew J Bauer2, Amber Isaza2, Sogol Mostoufi-Moab2, Ken Kazahaya3, N Scott Adzick4.   

Abstract

BACKGROUND: Recent studies suggest improved outcomes for children undergoing thyroidectomy at high-volume pediatric surgery centers. We present outcomes after thyroid surgery at a single center and advocate for referral to high-volume centers for multidisciplinary management of these children.
METHODS: Medical records were reviewed for all pediatric patients undergoing thyroid surgery at a single institution from 2009 through 2017. Routine recurrent laryngeal nerve and parathyroid hormone monitoring was used. Lymph node dissections were performed in appropriately selected cancer patients. Data collection focused on pathologic diagnosis, surgical technique, and surgical complications, including postoperative hematoma, neurapraxia, permanent nerve damage, hypocalcemia, and transient and permanent hypoparathyroidism.
RESULTS: From 2009 through 2017, 464 patients underwent thyroid surgery. Median age of the cohort was 15 years (range 2-24). Thirty-three percent were diagnosed with benign nodules (n=151), 36% with papillary or follicular thyroid cancer (n=168), 27% with Graves' disease (n=124), 3% with medullary thyroid cancer (n=14), and 1.5% underwent prophylactic thyroidectomy for MEN2a (n=7). Six patients required return to the OR for hematoma evacuation including 5 patients after surgery for Graves' disease (RR 8.7, 95% CI 1.06-71.85). In sixteen cases, concern about neurapraxia resulted in laryngoscopy, revealing eleven patients with vocal cord paresis. Two of these patients demonstrated a persistent deficit at 6 months postoperatively (0.4%). Thirty-seven percent of patients had transient hypoparathyroidism (n=137), and two patients had persistent hypoparathyroidism 6 months after total thyroidectomy (0.6%). There was no significant difference in either hypocalcemia or hypoparathyroidism after total thyroidectomy based on age or diagnosis.
CONCLUSIONS: Characterizing outcomes for pediatric patients based on diagnosis will assist in preoperative counseling for patients and their families. This high-volume center reports low complication rates after pediatric thyroid surgery, highlighting that referral to high-volume centers should be considered for children and adolescents with thyroid disease requiring surgery. LEVEL OF EVIDENCE: Level IV.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Graves’ disease; High-volume center; Hypocalcemia; Hypoparathyroidism; Modified radical neck dissection; Multidisciplinary team; Neurapraxia; Operative volume; Papillary thyroid cancer; Pediatric endocrine surgeon; Pediatric thyroidectomy; Radioactive iodine ablation; Recurrent laryngeal nerve injury

Year:  2019        PMID: 30902456     DOI: 10.1016/j.jpedsurg.2019.02.009

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  18 in total

1.  Surgical treatment of children Graves' disease with huge goiter-a case report and literature review.

Authors:  Yao Li; Xiang Cui; Yongjun Yang; Yan Liang; Fan Chai; Yi-Ceng Sun; Cong Shao; Hongbiao Mo; Supeng Yin; Zeyu Yang; Fan Zhang
Journal:  Gland Surg       Date:  2020-04

2.  Thyroidectomy in Pediatric Patients with Graves' Disease: A Systematic Review of Postoperative Morbidity.

Authors:  Annabel S Zaat; Joep P M Derikx; Nitash Zwaveling-Soonawala; A S Paul van Trotsenburg; Christiaan F Mooij
Journal:  Eur Thyroid J       Date:  2020-11-17

3.  Ultrasound findings of the thyroid gland in children and adolescents.

Authors:  Elena Moschos; Hans-Joachim Mentzel
Journal:  J Ultrasound       Date:  2022-02-09

4.  Clinical Heterogeneity of Differentiated Thyroid Cancer between Children Less than 10 Years of Age and Those Older than 10 Years: A Retrospective Study of 70 Cases.

Authors:  Yuwei Liu; Shengcai Wang; Yanzhen Li; Xuexi Zhang; Zhiyong Liu; Qiaoyin Liu; Nian Sun; Jie Zhang; Wentong Ge; Yongli Guo; Yuanhu Liu; Xiaolian Fang; Tingting Ji; Jun Tai; Xin Ni
Journal:  Eur Thyroid J       Date:  2021-06-17

5.  Trans-oral endoscopic thyroidectomy vestibular approach (TOETVA) for the pediatric population: a multicenter, large case series.

Authors:  Oded Cohen; Ralph P Tufano; Angkoon Anuwong; Jonathon O Russell; Niddal Assadi; Gianlorenzo Dionigi; Hoon Yub Kim; Antonio Bertelli; Avi Khafif
Journal:  Surg Endosc       Date:  2021-05-24       Impact factor: 4.584

6.  Metastatic Papillary Thyroid Carcinoma in a Paediatric Patient.

Authors:  Nthabiseng Ellen Mothata; Takalani Gidion Morulana; Nyaweleni Tshifularo; Phumudzo Bridgett Nemutaduni; Nozipho Elizabeth Nyakale; Moshawa Calvin Khaba
Journal:  Case Rep Endocrinol       Date:  2021-01-05

Review 7.  Intraoperative Recurrent Laryngeal Nerve Monitoring During Pediatric Cardiac and Thoracic Surgery: A Mini Review.

Authors:  Claire M Lawlor; Benjamin Zendejas; Christopher Baird; Carlos Munoz-San Julian; Russell W Jennings; Sukgi S Choi
Journal:  Front Pediatr       Date:  2020-11-27       Impact factor: 3.418

8.  Thyroid surgery in children and young adults: potential overtreatment and complications.

Authors:  Julia I Staubitz; Julia Bode; Alicia Poplawski; Felix Watzka; Joachim Pohlenz; Hauke Lang; Thomas J Musholt
Journal:  Langenbecks Arch Surg       Date:  2020-05-27       Impact factor: 3.445

9.  Thyroid surgery in 103 children in a single institution from 2000-2014.

Authors:  Osama Ibrahim Almosallam; Ali Aseeri; Ahmed Alhumaid; Ali S AlZahrani; Saif Alsobhi; Saud AlShanafey
Journal:  Ann Saudi Med       Date:  2020-08-06       Impact factor: 1.526

10.  Clinical Utility of Intraoperative Parathyroid Hormone Measurement in Children and Adolescents Undergoing Total Thyroidectomy.

Authors:  Steven D Tsai; Sogol Mostoufi-Moab; Samantha Bauer; Ken Kazahaya; Colin P Hawkes; N Scott Adzick; Andrew J Bauer
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-06       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.